id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-0329-0010,FDA,FDA-2014-D-0329,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2018-03-22T04:00:00Z,2018,3,2018-03-22T04:00:00Z,,2018-03-22T14:43:15Z,2018-05797,0,0,090000648303f12e
FDA-2014-D-0329-0008,FDA,FDA-2014-D-0329,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Fees for Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and Cosmetic Act",Notice,30 Day Proposed Information Collection,2017-10-16T04:00:00Z,2017,10,2017-10-16T04:00:00Z,2017-11-16T04:59:59Z,2017-11-14T02:03:22Z,2017-22283,0,0,0900006482bcde53
FDA-2014-D-0329-0007,FDA,FDA-2014-D-0329,"Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Fees for Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and Cosmetic Act",Notice,60 Day Proposed Information Collection,2017-06-15T04:00:00Z,2017,6,2017-06-15T04:00:00Z,2017-08-15T03:59:59Z,2017-06-15T14:09:31Z,2017-12353,0,0,09000064826dbc34
FDA-2014-D-0329-0004,FDA,FDA-2014-D-0329,Fees for Human Drug Compounding Outsourcing Facilities Under the FD&C Act; Guidance for Industry; Availability,Notice,Notice of Availability,2014-11-24T05:00:00Z,2014,11,2014-11-24T05:00:00Z,,2017-04-05T13:49:47Z,2014-27692,0,0,0900006481941448
FDA-2014-D-0329-0005,FDA,FDA-2014-D-0329,Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act; Guidance for Industry,Other,Guidance,2014-11-24T05:00:00Z,2014,11,2014-11-24T05:00:00Z,,2024-11-12T05:29:28Z,,1,0,0900006481941995
FDA-2014-D-0329-0003,FDA,FDA-2014-D-0329,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Guidance for
Industry on Fees for Human Drug Compounding Outsourcing Facilities
Under the Federal Food, Drug, and Cosmetic Act",Notice,60 Day Proposed Information Collection,2014-09-02T04:00:00Z,2014,9,2014-09-02T04:00:00Z,2014-10-03T03:59:59Z,2017-04-05T13:49:04Z,2014-20719,0,0,09000064818537a1
FDA-2014-D-0329-0001,FDA,FDA-2014-D-0329,"Guidance for Industry on Fees for Human Drug Compounding
Outsourcing Facilities Under the Federal Food, Drug, and Cosmetic Act;
Availability",Notice,Notice of Availability,2014-04-01T04:00:00Z,2014,4,2014-04-01T04:00:00Z,2014-06-03T03:59:59Z,2014-05-31T01:07:18Z,2014-06884,0,0,0900006481694a6b
FDA-2014-D-0329-0002,FDA,FDA-2014-D-0329,Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act Guidance for Industry,Other,Guidance,2014-04-01T04:00:00Z,2014,4,2014-04-01T04:00:00Z,,2024-11-07T23:05:24Z,,1,0,0900006481694c66